IPA to Present at The Microcap Conference 2025
-
Bullying claims 'nonsense', actress Rebel Wilson tells Sydney court
-
BP reports huge profit rise in first quarter
-
Crude extends gains, stocks drop as Trump considers latest Iran proposal
-
How China block of AI deal could stop 'Singapore-washing'
-
North Korean executions rose dramatically during Covid: report
-
Budget airlines first to cut flights as jet fuel prices soar
-
Simeone, Atletico chasing redemption against Arsenal
-
'Bring it on', says Rice as Arsenal chase Champions League history
-
US says examining latest Iran proposal
-
S. Korea probes syringe hoarding as war hits plastic makers
-
Australia aims to tax tech giants unless they pay news outlets
-
Bangladesh's tigers stalk uncertain future in Sundarbans
-
Horses unlikely saviours for those who serve in uniform
-
Crude extends gains as Trump considers latest Iran proposal
-
Nations to kick off world-first fossil fuel exit talks
-
Philippine museum brings deadly, lucrative galleon trade to life
-
Opening remarks Tuesday in Elon Musk versus OpenAI
-
New York restaurant's $40 half chicken fuels cost of dining debate
-
Trump shooting scare renews 'staged' conspiracy theory
-
LIV Golf postpones June event set for New Orleans: reports
-
Kingfisher Metals Confirms Early Jurassic Porphyry Mineralization Across Hank-Mary District, a Fertile Window Between Mitchell Cu-Au and Brucejack Au-Ag Deposits
-
Star Copper Completes Copperline Project Inaugural 2025 Field Program at Omineca Mining Division, BC
-
BioNxt Applies Advanced Drug Delivery Strategy and Psychedelic Compound Library to Emerging Therapeutics Market Amid Accelerating Global Momentum
-
SphingoTec Introduces ELISA sphingotest(R) penKid(R) to Enable Broad Kidney Biomarker Testing for Research Applications
-
Apex Drills 4.02% REO over 23.7 m, within Broader 124 m Zone at 1.94% REO, Extending Mineralization Significantly to the South
-
Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise
-
Caledonia Mining Corporation Plc: Notice of Q1 2026 Results and Investor Presentation
-
Genflow Biosciences PLC Announces Expansion of Confidentiality Agreements
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 28
-
Colombian peace accord failed to protect nature: ex-leader Santos
-
Nations have chance to break 'fossil fuel mindset': Mary Robinson
-
Colombia in mourning after deadliest attack in decades
-
Jury in place for Elon Musk's legal battle with OpenAI
-
Weinstein rape accuser gives emotional testimony at US retrial
-
Rybakina crashes out of Madrid Open, Sabalenka reaches quarters
-
Trump and team renew attacks on adversaries after gala shooting
-
Carrick hails Casemiro and Fernandes after vital Man Utd win
-
Felix, 40, says she plans comeback for LA Olympics
-
French FM says Iran must make 'major concessions' to end crisis
-
Trains collide near Jakarta, killing five, injuring dozens
-
Britain's King Charles meets Trump in bid to salvage ties
-
Accused media gala gunman charged with attempting to assassinate Trump
-
Man Utd beat Brentford to close on Champions League berth
-
Third suspect pleads guilty in US murder of Jam Master Jay
-
Milei bars media from presidential palace
-
California billionaire tax appears headed to the ballot
-
Trains collide near Jakarta, killing four, injuring dozens
-
Kompany hails Kane, 'ageing like fine wine' as Bayern face PSG in Champions League
-
UK's King Charles arrives in US to shore up Trump ties
-
Tuareg rebels in control of key Mali town
IPA to Present at The Microcap Conference 2025
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, in Atlantic City, NJ.
IPA's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
The 2025 event will feature:
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit https://themicrocapconference.com.
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and is known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the "IPA Family").
Investor Relations Contact
SOURCE: ImmunoPrecise Antibodies Ltd.
P.Mathewson--AMWN
